loading

Crinetics Pharmaceuticals Inc Aktie (CRNX) Neueste Nachrichten

pulisher
Nov 21, 2025

What technical signals suggest for Crinetics Pharmaceuticals Inc. stockTake Profit & Risk Controlled Stock Pick Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

United States Congenital Adrenal Hyperplasia Treatment - openPR.com

Nov 21, 2025
pulisher
Nov 21, 2025

Can Crinetics Pharmaceuticals Inc. stock sustain revenue growthJuly 2025 Movers & Daily Risk Controlled Trade Plans - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Crinetics Pharmaceuticals Inc. stock a safe haven assetPortfolio Risk Summary & Real-Time Sentiment Analysis - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How strong dollar benefits Crinetics Pharmaceuticals Inc. (6Z4) stockGlobal Markets & High Return Stock Watch Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Price-Driven Insight from (CRNX) for Rule-Based Strategy - news.stocktradersdaily.com

Nov 20, 2025
pulisher
Nov 20, 2025

Crinetics begins Phase 3 trial of oral therapy for carcinoid syndrome - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Crinetics Pharmaceuticals Begins Phase 3 Trial of Paltusotine in Carcinoid Syndrome - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Crinetics (CRNX) Begins Phase 3 Trial for Paltusotine Treatment - GuruFocus

Nov 20, 2025
pulisher
Nov 20, 2025

Crinetics announces first patient randomized in pivotal phase 3 CAREFNDR trial evaluating paltusotine in carcinoid syndrome - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Crinetics Announces First Patient Randomized in Pivotal Phase 3 CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome - The Manila Times

Nov 20, 2025
pulisher
Nov 20, 2025

Crinetics Pharmaceuticals Advances Phase 3 CAREFNDR Trial for Paltusotine in Treating Carcinoid Syndrome - Quiver Quantitative

Nov 20, 2025
pulisher
Nov 20, 2025

Crinetics (Nasdaq: CRNX) Starts Phase 3 CAREFNDR Trial for 141 Carcinoid Patients - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Using data tools to time your Crinetics Pharmaceuticals Inc. exit2025 Year in Review & Fast Gain Stock Trading Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Sector ETF performance correlation with Crinetics Pharmaceuticals Inc.Entry Point & High Accuracy Swing Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Crinetics Pharmaceuticals Inc. (6Z4) stock attracts HNW investors2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Crinetics Pharmaceuticals Inc. (6Z4) stock cheap by valuation metricsMarket Volume Summary & Safe Capital Growth Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Crinetics Pharmaceuticals Inc. stock a safe buy before earningsQuarterly Trade Report & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Crinetics Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Closing Moves & Daily Momentum Trading Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Crinetics Pharmaceuticals Inc.’s volatility index tracking explained2025 Buyback Activity & Reliable Entry Point Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Crinetics Pharmaceuticals Inc. rally from current levels2025 Year in Review & Short-Term Trading Opportunity Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What institutional flow reveals about Crinetics Pharmaceuticals Inc. - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Crinetics Pharmaceuticals Inc. (6Z4) stock supported by free cash flowMarket Growth Summary & Free High Return Stock Watch Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Quantitative breakdown of Crinetics Pharmaceuticals Inc. recent moveJuly 2025 Movers & Expert Approved Momentum Ideas - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Automated trading signals detected on Crinetics Pharmaceuticals Inc.Long Setup & AI Enhanced Market Trend Forecasts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Will Crinetics Pharmaceuticals Inc. stock deliver better than expected guidance2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Chart based analysis of Crinetics Pharmaceuticals Inc. trendsMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Top chart patterns to watch in Crinetics Pharmaceuticals Inc.2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Backtesting results for Crinetics Pharmaceuticals Inc. trading strategiesStop Loss & Long-Term Safe Investment Ideas - newser.com

Nov 17, 2025
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):